🇺🇸 FDA

Company profile · Sponsor

CRESCENT

CRESCENT BIOPHARMA, INC.

CBIO · NYSE biotech WALTHAM, MA, USA
Pipeline
3
Drugs
0
Patents
2

Quick answer

CRESCENT (CBIO) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 2 patents to this profile..

Company facts

Ticker CBIO
Exchange NYSE
Company type biotech
Headquarters WALTHAM, MA, USA
SEC CIK 0001253689

Pipeline (3)

Search pipeline →

  1. CR-001

    CRESCENT

    Locally Advanced / Metastatic Solid Tumors

    phase 2 small molecule active

    1 trial

  2. Chlorhexidine

    CRESCENT

    Neonatal Infections

    approved small molecule completed

    1 trial

  3. Folic acid

    CRESCENT

    Acute Myocardial Infarction

    small molecule completed

    1 trial

Patents (2)

Search patents →

  1. US 12138243

    Antiviral use of FABP4 modulating compounds

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12084419

    Cell metabolism modulating compounds and uses thereof

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is CRESCENT?

CRESCENT (CBIO) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 2 patents to this profile..

What pipeline programs does CRESCENT sponsor?

We track 3 ClinicalTrials.gov-linked programs for CRESCENT, including CR-001 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does CRESCENT company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.